Amgen Inc. (AMGN)

$ 402.60
   
  • Change Today:
    $-0.38
  • 52 Week High: $444.91
  • 52 Week Low: $290.13
  • Currency: US Dollars
  • Shares Issued: 538.80m
  • Volume: 2,036,870
  • Market Cap: $216,921m
  • RiskGrade: 100
  • Beta: 0.02

Latest ShareCast News

Amgen buys UK biotech Dark Blue Therapeutics for up to $840m

By Michele Maatouk

Date: Tuesday 06 Jan 2026

(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 402.60
Change Today $ -0.38
% Change -0.09 %
52 Week High $444.91
52 Week Low $290.13
Volume 2,036,870
Shares Issued 538.80m
Market Cap $216,921m
Beta 0.02
RiskGrade 100

What The Brokers Say

Strong Buy 6
Buy 6
Neutral 17
Sell 3
Strong Sell 1
Total 33
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Oct-2026

Time Volume / Share Price
15:59 59 @ $402.74
15:59 81 @ $402.74
15:59 140 @ $402.71
15:59 40 @ $402.73
15:59 40 @ $402.75

Top of Page